Related Experiment Video
Updated: Sep 30, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
Cardiac morbidity & mortality in patients with breast cancer: A review
Aruna Alahari Dhir1, Sheela Prashant Sawant1
1Department of Medicine, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Insights
Breast cancer survivors face higher risks of cardiovascular disease (CVD) mortality due to shared risk factors and cardiotoxic cancer treatments. Managing CVD is crucial for improving long-term survival and quality of life.
Area of Science:
- Oncology
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) and breast cancer are leading causes of morbidity and mortality in women.
- Breast cancer survivors exhibit increased risk for CVD-related mortality.
- Shared risk factors contribute to the co-occurrence of these conditions.
Purpose of the Study:
- To highlight the significant public health concern of CVD in breast cancer patients.
- To emphasize the cardiotoxic potential of breast cancer treatments.
- To underscore the importance of assessing and managing CVD in breast cancer survivors.
Main Methods:
- Review of existing literature on breast cancer treatment and cardiovascular complications.
- Analysis of shared risk factors between breast cancer and CVD.
- Examination of cardiotoxicity associated with chemotherapy, targeted therapy, and radiation.
Main Results:
- Breast cancer survivors have a demonstrably higher risk of CVD mortality.
- Common risk factors link breast cancer and cardiovascular diseases.
- Cancer therapies, including anthracyclines and radiation, can induce cardiotoxicity.
Conclusions:
- Improved breast cancer survival necessitates a focus on long-term treatment effects, particularly cardiovascular health.
- Proactive assessment and mitigation of CVD complications are essential components of breast cancer care.
- Managing cardiovascular risks is vital for enhancing the quality of life for breast cancer survivors.
Abstract:
Cardiovascular disease (CVD) and breast cancer cause substantial morbidity and mortality in women and are major public health concerns. Breast cancer survivors are at a greater risk for CVD-related mortality compared to women without breast cancer. Breast cancer and cardiovascular diseases share a number of common risk factors. Breast cancer treatments like anthracycline based chemotherapy, novel targeted therapy and radiation therapy can cause cardiotoxicity. With improvements in breast cancer prevention and treatment, there is a significant improvement in survival and this shifts focus from disease control to long term effects of treatment and quality of life. Assessing CVD and minimizing complications from cancer therapy are important treatment goals.
Related Concept Videos
Mitral Stenosis IV: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Pericarditis IV: Nursing Management
Cancer Survival Analysis
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

